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Cytomegaloviris antibodies amongst immunocompro-
mised (HIV) patients at Lagos University Teaching Hospital
(LUTH) Idi-Araba, Lagos
A. Akinbami
LASUCOM, LAGOS, LAGOS, Nigeria
Background: CMV infection constitutes a real risk
of pathogenecity in immunocompromised patient. HIV-
infected patients who require transfusion are at high risk of
developing symptomatic CMV infection when they are trans-
fused with CMV-infected donor blood. This study intends
to determine the risk that blood transfusion poses in CMV
infection in a population of HIV- infected patients.
Methods: A study was carried out amongst clients attend-
ing HIV clinic at Lagos University Teaching Hospital (LUTH),
they were recruited consecutively. Replacement blood
donors of the hospitals were recruited as controls A total of
10mls of blood sample was collected per consenting partic-
ipant. The serum obtained from 5ml of blood was assayed
for CMV IgG/IgM using an enzyme- linked immunosorbent
assay (ELISA) based Kit whilst full blood count and CD4 cell
counts were also performed on the remaining 5mls. The
descriptive data was given as mean± standard deviation
(SD). Chi-squared test was used for the analytic assessment.
The differences were considered to be statistically signiﬁ-
cant when the p value obtained was less than 0.05.
Results: A total of 129 HIV-infected were studied. All
(100%) were IgG anti-CMV positive. 8 (6.6%) were IgM anti-
CMV positive. This difference was found to be statistically
signiﬁcant P = 0.004, (P < 0.05). Of 122 replacement blood
donor controls, 118 (96%) of them were IgG anti-CMV pos-
itive whilst 26 (19.5%) of 121 were IgM anti-CMV positive.
The mean CD4+ cell count of HIV-infected patients was
(234± 173.181). Previous history of blood transfusion did not
affect CMV antibody positivity directly.
Conclusion: The seroprevalence of CMV is very high in
HIV-infected patients, which is comparable to the sero-
prevalence amongst the general population The use of
leukoreduced blood units for anaemic HIV infected patients,
is recommended.
doi:10.1016/j.ijid.2010.02.2084
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Evaluation of Tanzania National Measles Surveillance Sys-
tem with laboratory component, for 2006 and 2007
D.M. Kadigi
Ministry of Health, Tanzania, Dar Es Salaam, Tanzania,
United Republic of
Background: Measles is among the seven vaccine pre-
ventable diseases of priority under the Expanded Program
on Immunization in Tanzania. The objectives of the measles
surveillance system which was established in 1975 are to
establish disease early detection, prevention, control of its
outbreak, monitor disease pattern and integrate enhanced
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urveillance for polio and measles cases. The objective of
his evaluation was to determine whether the surveillance
ystem is achieving its objectives, purposes and to asses its
ttributes.
Methods: Used the Centres for Disease Control and
revention (CDC) guideline document, discussions and
nterviews with different stakeholders, reviewing National
easles data for 2006 and 2007 with reference to WHO indi-
ators of quality measles surveillance system.
Results: There was a total of 7656 suspected measles
ases with 2871 (37.5%) of cases conﬁrmed by IgM labora-
ory testing which is above WHO target of 10%. The system
s highly sensitive with low Predictive Value Positive, ﬂex-
ble and acceptable. Not simple as it requires laboratory
onﬁrmation. Quality of data in terms of completeness and
imeliness is good with description of age and vaccination
tatus. There is poor data feedback communication with low
evels and between Expanded Programme in Immunization
eadquarters and Epidemiology Section.
Conclusion: The System mainly achieves its objectives
nd purposes, but should strengthen the timely distribution
f feedback to lower levels, and strengthens data commu-
ication with Epidemiology section, for better preparedness
n case of any outbreak.
oi:10.1016/j.ijid.2010.02.2085
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he ﬁrst needle and syringe exchange program in Iranian
risons
. Shahbazi1,∗, M. Farnia2, M. Keramati 2
GFATM (www.theglobalfund.org) - Iran prisons organiza-
ion, Tehran, Iran, Islamic Republic of
Tehran, Iran, Islamic Republic of
Background: Needle and syringe exchange programs
ithin prisons have been reported in international literature
o be associated with reduced blood-borne pathogens among
ntravenous (IV) drug users. Due to lack of previous evalu-
tions for its effect on prevalence of IV drug using among
ranian prisoners, herein we decided to perform the ﬁrst
valuation of this program in the Iranian prisons.
Methods: In a period of nine months, from July 2008 to
arch 2009, 347 volunteer prisoners enrolled and followed
p. All the volunteers were IV drug abusers. The program
ad been performed in three major prison centers in Iran,
ncluding Tehran, Isfahan and Hamadan. The prisoners were
iven sterile needles and syringes weekly, and the used
nes were also collected regularly. Data including number
f syringes and shared ones used by each person was col-
ected at the beginning of program; and this data was also
ocumented on a weekly basis as the program proceeded.
nformation regarding blood-borne diseases was also given
o the enrolled prisoners continuously.
Results: Among 347 volunteer prisoners enrolled in this
rogram, an average of 17 syringes were reported to be used
eekly for IV drug injection before starting the program.
oreover, the volunteers reported to use an average of 3.7
hared syringes during a week. Documented infection with
lood-borne diseases (including Human Immunodefﬁciency
irus, Hepatitis B or C) was also found in 44 prisoners. At
